Table 3.
Distribution of clinical endpoints by study group
| Experimental Intervention (n = 238) | Standard Care Control (n = 236) | |
|---|---|---|
| Cardiovascular death | 2 (0.8) | 2 (0.8) |
| Other death | 5 (2.1) | 0 (0.0) |
| Myocardial infarction | 5 (2.1) | 4 (1.7) |
| Acute coronary syndrome | 1 (0.4) | 2 (0.8) |
| Congestive heart failure | 5 (2.1) | 8 (3.4) |
| Stroke | 1 (0.4) | 1 (0.4) |
| Amputation above ankle | 2 (0.8) | 2 (0.8) |
| Dialysis | 2 (0.8) | 1 (0.4) |
| Doubled serum creatinine | 1 (0.4) | 4 (1.7) |
| Total cases with ≥1 event | 19 (8.0) | 19 (8.0) |
| Total events | 24 | 24 |
| Event rate per year (%) | 5.3 | 5.2 |
The proportions are presented as numbers (percentages).